Rosiglitazone
Rosiglitazone (Avandia) is a thiazolidinedione tablet used in the management of type 2 diabetes. This single-product listing covers the one formulation currently in the catalogue.
Key points
- Rosiglitazone has been recommended for withdrawal from clinical use in the UK following a safety review.
- The tablet is available in 2 mg and 4 mg strengths.
- GlaxoSmithKline is the originator behind the Avandia brand.
What Rosiglitazone is used for
Rosiglitazone is listed for type 2 diabetes mellitus, a condition in which the body does not use insulin effectively. For adults with this condition, rosiglitazone is taken as a tablet to keep blood sugar levels within a target range.
